These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2173022)

  • 1. Depression and antidepressant therapy: receptor dynamics.
    Zemlan FP; Garver DL
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(4):503-23. PubMed ID: 2173022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning.
    Sugrue MF
    Pharmacol Ther; 1983; 21(1):1-33. PubMed ID: 6312466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor alterations associated with serotonergic agents: an autoradiographic analysis.
    Wamsley JK; Byerley WF; McCabe RT; McConnell EJ; Dawson TM; Grosser BI
    J Clin Psychiatry; 1987 Mar; 48 Suppl():19-25. PubMed ID: 3029045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5HT1A receptors and pharmacotherapy. Is serotonin receptor down-regulation linked to the mechanism of action of antidepressant drugs?
    Stahl S
    Psychopharmacol Bull; 1994; 30(1):39-43. PubMed ID: 7972628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental basis for the antidepressant action of the GABA receptor agonist progabide.
    Bartholini G
    Neurosci Lett; 1984 Jun; 47(3):351-5. PubMed ID: 6089056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Receptor sensitivity and the mechanism of action of antidepressant treatment. Implications for the etiology and therapy of depression.
    Charney DS; Menkes DB; Heninger GR
    Arch Gen Psychiatry; 1981 Oct; 38(10):1160-80. PubMed ID: 6271089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-norepinephrine receptor interactions in the brain: implications for the pharmacology and pathophysiology of affective disorders.
    Sulser F
    J Clin Psychiatry; 1987 Mar; 48 Suppl():12-8. PubMed ID: 3029044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of prolonged administration of milnacipran, a new antidepressant, on receptors and monoamine uptake in the brain of the rat.
    Assie MB; Charveron M; Palmier C; Puozzo C; Moret C; Briley M
    Neuropharmacology; 1992 Feb; 31(2):149-55. PubMed ID: 1313158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for 5-HT in the action of antidepressant drugs.
    Cowen PJ
    Pharmacol Ther; 1990; 46(1):43-51. PubMed ID: 2181490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of electroconvulsive therapy and antidepressant drugs on monoamine receptors in rodent brain--similarities and differences.
    Green AR; Heal DJ; Goodwin GM
    Ciba Found Symp; 1986; 123():246-67. PubMed ID: 3028726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antidepressant drugs and central monoaminergic receptors].
    Asakura M; Tsukamoto T
    Yakubutsu Seishin Kodo; 1985 Dec; 5(4):303-19. PubMed ID: 2870595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanism of action of antidepressants and therapeutic perspectives].
    Bourin M; David DJ; Jolliet P; Gardier A
    Therapie; 2002; 57(4):385-96. PubMed ID: 12422559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta adrenergic receptor function in depression and the effect of antidepressant drugs.
    Pandey GN; Sudershan P; Davis JM
    Acta Pharmacol Toxicol (Copenh); 1985; 56 Suppl 1():66-79. PubMed ID: 2984893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regionally specific neural adaptation of beta adrenergic and 5-hydroxytryptamine2 receptors after antidepressant administration in the forced swim test and after chronic antidepressant drug treatment.
    Paul IA; Duncan GE; Powell KR; Mueller RA; Hong JS; Breese GR
    J Pharmacol Exp Ther; 1988 Sep; 246(3):956-62. PubMed ID: 2843636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-desalkylquetiapine, a potent norepinephrine reuptake inhibitor and partial 5-HT1A agonist, as a putative mediator of quetiapine's antidepressant activity.
    Jensen NH; Rodriguiz RM; Caron MG; Wetsel WC; Rothman RB; Roth BL
    Neuropsychopharmacology; 2008 Sep; 33(10):2303-12. PubMed ID: 18059438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of serotonin receptor subtypes by nortriptyline and adinazolam in major depressive disorder: neuroendocrine and platelet markers.
    Stahl SM; Hauger RL; Rausch JL; Fleishaker JC; Hubbell-Alberts E
    Clin Neuropharmacol; 1993; 16 Suppl 3():S19-31. PubMed ID: 8131152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of serotonin2 (5-HT2) receptors labeled with [3H]spiroperidol by chronic treatment with the antidepressant amitriptyline.
    Peroutka SJ; Snyder SH
    J Pharmacol Exp Ther; 1980 Dec; 215(3):582-7. PubMed ID: 6255132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple serotonin receptors and their physiological significance.
    Peroutka SJ; Snyder SH
    Fed Proc; 1983 Feb; 42(2):213-7. PubMed ID: 6337063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral studies of serotonin receptor agonists as antidepressant drugs.
    Lucki I
    J Clin Psychiatry; 1991 Dec; 52 Suppl():24-31. PubMed ID: 1684363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of serotonin type 2 (5-HT2) and beta-adrenergic receptors in rat cerebral cortex following novel and classical antidepressant treatment.
    Lafaille F; Welner SA; Suranyi-Cadotte BE
    J Psychiatry Neurosci; 1991 Nov; 16(4):209-14. PubMed ID: 1664741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.